Exhibit 10.78
-------------
ASSIGNMENT AGREEMENT
This Assignment Agreement (this "Agreement") is made and entered into as of
October 29, 2001 (the "Effective Date") by and between Agen Biomedical Limited,
an Australian company, having its principal place of business at 00 Xxxxxxx
Xxxxxx, Xxxxxx Xxxxx, Xxxxxxxxxx 0000, Xxxxxxxxx ("Agen"), and Synbiotics
Corporation, a California corporation, having its principal place of business at
00000 Xxx Xxxxxxxx, Xxx Xxxxx, XX 00000, Xxxxxx Xxxxxx of America
("Synbiotics").
RECITALS
Whereas, RM Diagnostics SAS entered into a Distribution Agreement dated July 9,
1997 with Rhone Merieux SAS for distribution of certain Witness products in
Japan (the "Distribution Agreement"),
Whereas, Synbiotics acquired all of the outstanding shares of RM Diagnostics
effective July 9, 1997,
Whereas, Agen and Synbiotics have entered into a License, Distribution and OEM
Agreement dated October 29, 2001,
Now, Therefore, in consideration of the mutual covenants contained herein and
for other good and valuable consideration the receipt of which is hereby
acknowledged, the Parties hereby agree as follows:
AGREEMENT
Synbiotics hereby assigns all of it's rights and interests in the Distribution
Agreement to Agen.
In Witness Whereof, the Parties have caused this Agreement to be executed by
duly authorized representatives of the Parties as of the Effective Date.
Agen Biomedical Ltd. Synbiotics Corporation
By: /s/ Xxxxxxx Xxxxxxxx By: /s/ Xxxx X. Rosinack
--------------------------------------- -------------------------------------
Signature Signature
Name: Xxxxxxx Xxxxxxxx Name: Xxxx X. Rosinack
Title: General Manager Title: President and CEO
